- Home
- NUE vs TEVA Comparison
NUE vs TEVA Comparison
Compare NUE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUE
- TEVA
- Stock Information
- Founded
- NUE 1905
- TEVA 1901
- Country
- NUE United States
- TEVA Israel
- Employees
- NUE N/A
- TEVA N/A
- Industry
- NUE Steel/Iron Ore
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- NUE Industrials
- TEVA Health Care
- Exchange
- NUE Nasdaq
- TEVA Nasdaq
- Market Cap
- NUE 29.2B
- TEVA 23.7B
- IPO Year
- NUE N/A
- TEVA N/A
- Fundamental
- Price
- NUE $125.03
- TEVA $21.83
- Analyst Decision
- NUE Buy
- TEVA Buy
- Analyst Count
- NUE 8
- TEVA 7
- Target Price
- NUE $163.63
- TEVA $22.43
- AVG Volume (30 Days)
- NUE 2.3M
- TEVA 8.9M
- Earning Date
- NUE 01-27-2025
- TEVA 01-29-2025
- Dividend Yield
- NUE 1.74%
- TEVA N/A
- EPS Growth
- NUE N/A
- TEVA N/A
- EPS
- NUE 10.40
- TEVA N/A
- Revenue
- NUE $31,362,946,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- NUE N/A
- TEVA $5.74
- Revenue Next Year
- NUE $0.78
- TEVA $4.46
- P/E Ratio
- NUE $12.03
- TEVA N/A
- Revenue Growth
- NUE N/A
- TEVA 9.81
- 52 Week Low
- NUE $112.25
- TEVA $11.48
- 52 Week High
- NUE $203.00
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- NUE 50.03
- TEVA 60.46
- Support Level
- NUE $116.24
- TEVA $21.21
- Resistance Level
- NUE $124.30
- TEVA $22.10
- Average True Range (ATR)
- NUE 3.19
- TEVA 0.62
- MACD
- NUE 1.93
- TEVA -0.11
- Stochastic Oscillator
- NUE 82.53
- TEVA 69.42
About NUE Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products, and raw materials, the steel mills segment derives maximum revenue. The steel mills segment includes carbon and alloy steel in sheet, bars, structural and plate; steel trading businesses; rebar distribution businesses; and Nucor's equity method investments in NuMit and NJSM.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.